Top Markets
#1 Black Phoenix Black Phoenix +355.20%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.60%
#4 Akedo Akedo +60.88%
#5 OpenEden OpenEden +54.74%
#6 Acurast Acurast +29.22%
#7 BasedHype BasedHype +27.20%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +18.96%
#10 Ether.fi Ether.fi +17.29%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cizzle Biotechnology Holdings Plc Cizzle Biotechnology Holdings Plc

Cizzle Biotechnology Holdings Plc

CIZ
Rang in Aktien #40703
Cizzle Biotechnology Holdings Plc specializes in developing an advanced... Cizzle Biotechnology Holdings Plc specializes in developing an advanced immunoassay diagnostic test. This innovative tool aims to identify the CIZ1B biomarker, facilitating the early detection of lung cancer. The company, previously known as Cizzle Biotechnology Limited, officially changed its corporate identity to Cizzle Biotechnology Holdings Plc in May 2021. Its main operational base is situated in London, United Kingdom.
Aktienkurs
$0.02245158
Marktkapitalisierung
$95.41K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
18.10%
Land
GB
Handel Cizzle Biotechnology Holdings Plc (CIZ)

Kategorie

Healthcare
Kursverlauf für Cizzle Biotechnology Holdings Plc (CIZ)
Höchster Schlusskurs: $0.02 am 2026-08-01

Niedrigster Schlusskurs: $0.10 am 2021-05-01
Kursverlauf der Aktie von Cizzle Biotechnology Holdings Plc von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 28.80%
2025 -4.03%
2024 -22.12%
2023 46.59%
2022 -54.13%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE